BAUSCH & LOMB POSTS 25% CONTACT LENS SALES GROWTH
This article was originally published in The Gray Sheet
Executive Summary
BAUSCH & LOMB POSTS 25% CONTACT LENS SALES GROWTH in the fourth quarter, "benefiting from sharply higher demand for SeeQuence and Medalist lenses used in planned replacement programs," the company said. B & L's Occasions line of frequent replacement multi-focal lenses "also aided these results." Worldwide contact lens revenues increased 13% for the year.
You may also be interested in...
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Stakeholders Devise Six-Point Plan To Improve Cross-Border Clinical Trials
Sponsors need guidance on ethics requirements and clarity around national regulations to conduct cross-border clinical trials in the EU, a multi-stakeholder forum says.